Search Results 41-50 of 11490 for MOTS-c Analogue

  1. Publications - William Tatum, D.O. - Mayo Clinic

    Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020 Sep 01; 95(9):e1244-e1256. Epub 2020 Jul 20.

  2. A Study To Evaluate The Safety And Effectiveness Of AMG 592 In Subjects With Steroid Refractory Chronic Graft Versus Host Disease - Mayo Clinic

    ... C antibody [HepCAb], followed by hepatitis C virus RNA by PCR if HepCAb is positive). Subjects with a history of hepatitis B vaccination without history ...

  3. Kahua Lawson Interface Processing Rules Quick Reference Guide

    ... C-ENTERPRISES XMAYO1-CSU-5F. MC00 ########## N. 65788793 1 157096. X ETT ADHESIVE/INFINITY. 210506420 MANNINGTON MILLS INC. 02/19/2018. 1.00. GA. 88.70. 88.70 ...

  4. Study Of INCB053914 In Subjects With Advanced Malignancies - Mayo Clinic

    About this study. This is an open-label, dose-escalation study of the proviral integration site of Moloney murine leukemia virus (PIM) kinase inhibitor ...

  5. ... MOT/DIFF,271 300000020,HC APOB APOLIPOPROTEIN E ... C CONFIRM TYPING LR,347 300000206,HC IGH GENE ... ANALOGS 5>,274 301000468,HC ORGANIC ACID 1 ...

  6. A Study To Evaluate ASP0367 In Participants With Primary Mitochondrial Myopathy (MOUNTAINSIDE) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness, safety and tolerability of ASP0367 in participants with Primary Mitochondrial Myopathy (PMM).

  7. Center for Cell Signaling in Gastroenterology (C-SiG)

    The Center for Cell Signaling in Gastroenterology (C-SiG) at Mayo Clinic studies the signaling pathways in gastrointestinal cells to treat GI diseases.

  8. Rem-422, An MYB MRNA Degrader, In Patients With Relapsed/Refractory AML Or Higher-Risk MDS - Mayo Clinic

    Evidence of active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Primary immunodeficiency. Current or expected need for daily systemic ...

  9. A Study to Assess AC220 Given in Combination with Induction and Consolidation Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML) - Mayo Clinic

    A known positive test for human immunodeficiency virus, hepatitis C, or hepatitis B surface antigen. Had major surgery within 4 weeks prior to the start of ...

  10. Publications - Thomas V. Colby, M.D. - Mayo Clinic

    Rossi G, Cavazza A, Colby TV. Pathology of sarcoidosis. Clin Rev Allergy Immunol. 2015 Aug; 49(1):36-44. View PubMed; Kim SY, Diggans J, ...